SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

P22102 (PUR2_HUMAN) Homo sapiens (Human)

Trifunctional purine biosynthetic protein adenosine-3 UniProtKBProtein AtlasInterProSTRINGInteractive Modelling

1010 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human aminoimidazole ribonucleotide synthetasehomo-2-mer475-792
99.68SO4;
Human GAR transformylase in complex with GAR substrate and AGF102 inhibitorhomo-2-mer808-1007
100GAR;V97;
Human glycinamide ribonucleotide synthetasemonomer1-429
99.76CL;SO4;ATP;GOL;
The structure of human glycinamide ribonucleotide transformylase in complex with 10S-methylthio-DDA…monomer808-1010
100PO4;SO4;DXY;
The structure of human glycinamide ribonucleotide transformylase in complex with 10R-methylthio-DDA…monomer808-1010
100PO4;SO4;DXZ;
human glycinamide ribonucleotide Transformylase at pH 4.2monomer808-1010
100.0PO4;SO4;
High resolution structure of human glycinamide ribonucleotide transformylase in apo form.monomer810-1010
100PO4;SO4;
Human GAR transformylase in complex with GAR and N-({5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d…monomer808-1008
100GAR;G71;
HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (S)-2-({4-[3-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO…monomer808-1007
100GAR;3YF;
HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (S)-2-({5-[3-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO…monomer808-1007
100GAR;3YG;
Human GAR transformylase in complex with GAR and (S)-2-(7-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3…monomer808-1007
100GAR;3YD;
Human GAR transformylase in complex with GAR and (S)-2-({4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo…monomer808-1007
100GAR;3YB;
Human GAR transformylase in complex with GAR and (S)-2-(8-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3…monomer808-1007
100GAR;3YE;
Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-…monomer808-1007
100GAR;3Y9;
Human GAR transformylase in complex with GAR and (S)-2-({5-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo…monomer808-1007
100GAR;3YC;
Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-3,4-dihydrothieno[2,3-d]pyr…monomer808-1007
100GAR;3YA;
human GAR Tfase in complex with hydrolyzed form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-…monomer808-1007
100PO4;KEU;
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…monomer808-1007
100KT5;
Human GAR transformylase in complex with GAR and N-({5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d…monomer808-1007
100GAR;G94;
Human GAR transformylase in complex with GAR substrate and AGF132 inhibitormonomer808-1007
100GAR;XSI;
The structure of human glycinamide ribonucleotide transformylase in complex with alpha,beta-N-(hydr…monomer808-1007
100GRF;DQB;
AGF271 and GAR in complex with human recombinant GARFTase, ligase, purine biosynthesis, transfers f…monomer808-1007
100GAR;XRR;
Human GAR transformylase in complex with GAR substrate and AGF347 inhibitormonomer808-1007
100GAR;Y79;
Human GAR transformylase in complex with GAR substrate and AGF103 inhibitormonomer808-1007
100GAR;V9A;NA;
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…monomer808-1007
100KT5;
Human GAR transformylase in complex with GAR and (4-{[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d…monomer808-1007
99.5GAR;83A;
Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrof…monomer808-1007
100KEU;GAR;
Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrof…monomer808-1007
100PO4;KEU;
Human GAR transformylase in complex with GAR substrate and AGF320 inhibitormonomer808-1007
100Y7L;GAR;
The apo structure of human glycinamide ribonucleotide transformylasemonomer808-1007
100GOL;
Human GAR transformylase in complex with GAR substrate and AGF305 inhibitormonomer808-1007
99.5GAR;XSO;
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…monomer808-1007
100PO4;KT3;
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…monomer808-1007
100PO4;KT5;
Human GAR transformylase in complex with GAR substrate and AGF131 inhibitormonomer808-1007
100GAR;V9V;NA;
Human GAR transformylase in complex with GAR substrate and AGF302 inhibitormonomer808-1007
100GAR;XSO;
Human GAR transformylase in complex with GAR and pemetrexedmonomer808-1007
1004DW;GAR;
Human GAR transformylase in complex with GAR substrate and AGF362 inhibitormonomer808-1007
100GAR;Y72;
Human GAR transformylase in complex with GAR substrate and AGF291 inhibitormonomer808-1007
100GAR;Y6U;
Human Glycinamide Ribonucleotide Transformylase domain at pH 8.5monomer810-1007
100PO4;
complex structure of human GAR Tfase and substrate beta-GARmonomer810-1007
100GAR;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2qk4.1.Amonomer0.891-428
ATP;99.77
1cli.3.Amonomer0.72433-778
47.95

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22qk4.1.Amonomer0.931-429
ATP;99.77